Aethlon Medical Inc (AEMD) Actualités

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update PR Newswire SAN...

Form 8-K - Current report

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia PR Newswire SAN...

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024 PR Newswire SAN DIEGO, Nov. 6...

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit PR Newswire SAN DIEGO, Oct. 8, 2024 SAN DIEGO, Oct. 8, 2024...

Form 8-K - Current report

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India PR Newswire SAN DIEGO, Sept. 19, 2024 Aethlon Medical Granted...

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial PR...